If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

Share Price is delayed by 15 minutes
Get Live Data
677.80    -8.60 (-1.25%)
Bid:
679.80
Ask:
680.00
Spread: 0.20 (0.029%)
Market Cap: £53.95b
NWG Live PriceLast checked at - London Stock Exchange

Intraday Natwest Share Chart

Directorate Change

16 Dec 2022 09:33

RNS Number : 9997J
NatWest Group plc
16 December 2022
 

16 December 2022

NatWest Group plc

Directorate change

 

NatWest Group plc ('NWG') announces that Stuart Lewis will be appointed as an independent non-executive director and member of the Group Board Risk Committee on 1 April 2023. Subject to regulatory approval, Stuart Lewis will be appointed as Chairman of the Group Board Risk Committee ('BRC') on 1 August 2023.

 

Morten Friis has confirmed his intention to step down as a non-executive director with effect from the close of business on 31 July 2023. Morten will reach the 9 year point in his tenure on 1 April 2023, but has agreed to remain on the Board for an additional period to allow for an orderly handover of responsibilities to Stuart Lewis.

Howard Davies, Chairman of NWG, said:

"I would like to thank Morten for his commitment, diligence and immense contribution since joining as a non-executive director in 2014. He has approached the role of BRC Chair with great skill and care and we have benefitted significantly from his expertise and wise counsel. My Board colleagues and I wish him well for the future. 

I am delighted that Stuart is joining the Board as a non-executive director in April, in advance of taking on the BRC Chair role, subject to regulatory approval. Stuart will bring extensive risk management and financial services experience to the Board, having spent the majority of his executive career with Deutsche Bank, most recently as Group Chief Risk Officer and a member of the management board of Deutsche Bank AG." 

There are no further matters requiring disclosure under Listing Rule 9.6.13.

For further information contact:

NatWest Group Investor Relations:

Alexander Holcroft

Head of Investor Relations

+44 (0) 20 7672 1758

 

NatWest Group Media Relations:

+44 (0) 131 523 4205

 

LEI: 2138005O9XJIJN4JPN90

Stuart Lewis Biography

Stuart Lewis served 10 years on the Management Board of Deutsche Bank as Chief Risk Officer, retiring in May 2022. Since joining Deutsche Bank in 1996, he held senior roles including Deputy Chief Risk Officer, Global Chief Credit Officer and Chief Credit Officer for Asia Pacific. He was previously Head of European Credit Risk Management at Credit Suisse Financial Products. In 2013, Stuart was elected to the Global Association of Risk Professionals (GARP) Board of Trustees. He was also a Member of the Foundation Board of the International Financial Risk Institute (IFRI) and served as Chair from 2016 to 2018. Stuart is a visiting Professor in Practice in the Finance Department of the London School of Economics (LSE). Stuart attended the University of Dundee where he obtained an LLB (Hons). He also holds a LLM (Merit) from the London School of Economics and took the Law Society finals examinations at the College of Law, Guildford.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKQLBFLLLXFBF
Date   Source Headline
24th Feb 20257:00 amRNSFiling of Annual Report on Form 20-F with US SEC
21st Feb 20254:50 pmRNSPublication of Final Terms
21st Feb 202510:29 amRNSNotice of Redemption
14th Feb 20254:05 pmRNSPublication of Suppl.Prospcts
14th Feb 20257:00 amRNSHolding(s) in Company - HMT
14th Feb 20257:00 amRNSNatWest Group plc - Annual Report
14th Feb 20257:00 amRNSNatWest Group plc 2024 Annual Results
31st Jan 20253:33 pmRNSTotal Voting Rights
28th Jan 202510:30 amRNSHolding(s) in Company – HMT shareholding
14th Jan 202510:30 amRNSHolding(s) in Company - HMT shareholding
3rd Jan 20252:00 pmRNSDirector/PDMR Shareholding
31st Dec 20241:06 pmRNSTotal Voting Rights
13th Dec 202411:15 amRNSAppointment of Chief Governance Officer
13th Dec 202410:30 amRNSHolding(s) in Company - HMT
13th Dec 20249:00 amRNSDirectorate Change
6th Dec 20241:47 pmRNSPublication of Prospectus
29th Nov 202412:44 pmRNSTotal Voting Rights
26th Nov 20242:00 pmRNSDirector/PDMR Shareholding
22nd Nov 202410:30 amRNSHolding(s) in Company – HMT shareholding
21st Nov 202410:10 amRNSHolding(s) in Company Capital Group Companies Inc.
18th Nov 20244:24 pmRNSDividend Declaration
18th Nov 20243:00 pmRNSDirector/PDMR Shareholding
15th Nov 20249:41 amRNSNatWest Group plc Filing of Registration Statement
13th Nov 20241:36 pmRNSHolding(s) in Company - HMT Shareholding
13th Nov 20241:11 pmRNSTotal Voting Rights
12th Nov 20242:00 pmRNSDirector/PDMR Shareholding
12th Nov 20247:00 amRNSQ3 2024 Pillar 3
11th Nov 20247:01 amRNSOff-Market Purchase of Ordinary Shares from HMT
11th Nov 20247:00 amRNSDisposal of Shares in NatWest Group plc for £1bn
8th Nov 20242:00 pmRNSDirector/PDMR Shareholding
6th Nov 20241:18 pmRNSNotice of Redemption
31st Oct 20241:02 pmRNSTotal Voting Rights
31st Oct 202410:30 amRNSHolding(s) in Company -HMT
25th Oct 20243:58 pmRNSPublication of Supplementary Prospectus
25th Oct 20247:00 amRNSNWG plc Q3 Results 2024
9th Oct 202410:30 amRNSHolding(s) in Company -HMT
2nd Oct 20244:00 pmRNSDirector/PDMR Shareholding
2nd Oct 202410:57 amRNSBlock Listing Six Monthly Return
30th Sep 20241:07 pmRNSTotal Voting Rights
27th Sep 202412:30 pmRNSDirector Declaration
26th Sep 20241:47 pmRNSNotice of Redemption
24th Sep 20248:00 amRNSBank of America Financials CEO Conference
23rd Sep 202410:30 amRNSHolding(s) in Company - HMT
17th Sep 20244:00 pmRNSDirector/PDMR Shareholding
13th Sep 20244:57 pmRNSPublication of Final Terms
11th Sep 20249:30 amRNSDirector Declaration
10th Sep 20246:02 pmRNSPublication of Final Terms
10th Sep 20243:00 pmRNSDirector/PDMR Shareholding
10th Sep 202412:00 pmRNSBarclays Global Financial Services Conference
30th Aug 202411:31 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.